New study tests better way to rebuild jawbone for dental implants

NCT ID NCT07613047

Not yet recruiting Disease control Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two barrier materials used in guided bone regeneration to rebuild the jawbone in areas where teeth are missing. Seventy adults needing horizontal ridge augmentation will be randomly assigned to receive either acellular dermal matrix or a resorbable collagen membrane. The goal is to see which material better restores bone width and improves soft tissue outcomes for future dental implants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: acellular dermal matrix (AlloDerm) and resorbable cross-linked collagen membrane
What this could lead to: If successful, this could show that acellular dermal matrix is a better option for rebuilding jawbone width, potentially improving dental implant success.
What could go wrong: This is an early-stage study with only 70 participants, so results may not apply to everyone. The procedure involves surgery with risks like pain, swelling, or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACELLULAR DERMAL MATRIX are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACELLULAR DERMAL MATRIX BONE GRAFTING SOFT TISSUE GRAFTING

Contacts and locations

Locations

University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.